About Dynatronics (NASDAQ:DYNT)
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company's products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals. Its physical medicine products include therapeutic modalities, such as Dynatron Solaris, including electrotherapy and thermal therapy, and 25 Series, including electrotherapy and ultrasound; manufactured capital products, including traction systems and wood furniture; manufactured supplies, including cold packs, straps, wedges, bolsters and mats; distributed capital products, including hydrotherapy, weight training equipment and pilates, and distributed supplies, including clinical accessories, sports med and taping products, lotions and gels.
Industry, Sector and Symbol
Industry MED PRODS
Trailing P/E Ratio-2.65217391304348
Forward P/E Ratio-6.78
Sales & Book Value
Annual Sales$35.76 million
Price / Sales0.68
Price / CashN/A
Book Value$0.82 per share
Price / Book3.72
Return on Equity-21.77%
Return on Assets-3.72%
Dynatronics (NASDAQ:DYNT) Frequently Asked Questions
What is Dynatronics' stock symbol?
Dynatronics trades on the NASDAQ under the ticker symbol "DYNT."
How were Dynatronics' earnings last quarter?
Dynatronics Co. (NASDAQ:DYNT) posted its earnings results on Tuesday, February, 13th. The medical equipment provider reported ($0.23) earnings per share for the quarter. The medical equipment provider earned $18.09 million during the quarter. Dynatronics had a negative net margin of 2.56% and a negative return on equity of 21.77%. View Dynatronics' Earnings History.
When will Dynatronics make its next earnings announcement?
Who are some of Dynatronics' key competitors?
Some companies that are related to Dynatronics include PURE Bioscience (PURE), BioSig Technologies (BSGM), BIOLASE (BIOL), Reshape Lifesciences (RSLS), Capricor Therapeutics (CAPR), Imprimis Pharmaceuticals (IMMY), Rewalk Robotics (RWLK), Cesca Therapeutics (KOOL), Microbot Medical (MBOT), InVivo Therapeutics (NVIV), Valeritas (VLRX), Cellectar Biosciences (CLRB), Neurometrix (NURO), Check Cap (CHEK), SenesTech (SNES), Neovasc Inc (US) (NVCN), Sunshine Heart (CHFS) and Amedica (AMDA).
Who are Dynatronics' key executives?
Dynatronics' management team includes the folowing people:
- Erin S. Enright, Chairman of the Board (Age 56)
- Kelvyn H. Cullimore Jr., Chief Executive Officer, Director (Age 61)
- David Alma Wirthlin, Chief Financial Officer (Age 55)
- Brian D. Baker, President of Therapy Products Division
- Thomas J. Gephart, Senior Vice President - Sales
- Douglas G. Sampson, Vice President - Production and Research & Development (Age 61)
- Bryan David Alsop, Vice President - Information Technology (Age 53)
- Robert J. Cardon, Vice President - Administration, Treasurer, Secretary (Age 52)
- Skyler Black, Corporate Controller
- Terry M. Atkinson CPA, Director of Accounting (Age 62)
Has Dynatronics been receiving favorable news coverage?
Press coverage about DYNT stock has been trending somewhat negative recently, Accern Sentiment reports. Accern identifies negative and positive press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Dynatronics earned a news sentiment score of -0.02 on Accern's scale. They also gave news stories about the medical equipment provider an impact score of 46.07 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
How do I buy shares of Dynatronics?
Shares of DYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Dynatronics' stock price today?
One share of DYNT stock can currently be purchased for approximately $3.05.
How big of a company is Dynatronics?
Dynatronics has a market capitalization of $23.14 million and generates $35.76 million in revenue each year. The medical equipment provider earns $-1,860,000.00 in net income (profit) each year or ($1.15) on an earnings per share basis. Dynatronics employs 233 workers across the globe.
How can I contact Dynatronics?
Dynatronics' mailing address is 7030 PARK CENTRE DRIVE, COTTONWOOD HEIGHTS UT, 84121. The medical equipment provider can be reached via phone at 801-568-7000.
MarketBeat Community Rating for Dynatronics (DYNT)MarketBeat's community ratings are surveys of what our community members think about Dynatronics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Dynatronics (NASDAQ:DYNT) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Dynatronics (NASDAQ:DYNT) Earnings History and Estimates Chart
Dynatronics (NASDAQ DYNT) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/21/2018|| || || || || || || || |
|2/13/2018||Q2 2018||($0.23)||$18.09 million||View||N/A|
|11/14/2017||Q1 2018||($0.08)||$0.00||$12.80 million||View||N/A|
|9/27/2017||Q4 2017||($0.49)||($0.64)||$11.17 million||View||N/A|
|5/18/2017||Q3 2017||($0.20)||($0.28)||$7.72 million||View||N/A|
|2/13/2017||Q2 2017||($0.10)||($0.19)||$8.71 million||View||N/A|
|11/14/2016||Q1 2017||($0.03)||($0.13)||$7.40 million||$8.20 million||View||N/A|
|9/26/2016||Q416||($0.14)||($0.45)||$7.90 million||$8.13 million||View||Listen|
|5/16/2016||Q316||($0.02)||($0.19)||$7.00 million||$7.40 million||View||Listen|
|2/16/2016||Q216||($0.08)||($0.08)||$7.55 million||$7.50 million||View||Listen|
|11/13/2015||Q1||($0.10)||$7.20 million||$7.40 million||View||Listen|
|5/14/2015||Q3||($0.08)||$6.20 million||$6.70 million||View||N/A|
|11/14/2014||Q115||$0.02||$7.06 million||$7.22 million||View||N/A|
|5/13/2014||Q314||($0.06)||$7.07 million||$6.19 million||View||N/A|
|11/14/2013||Q313||($0.04)||$7.21 million||$7.06 million||View||N/A|
|5/14/2013||Q3 2013||($0.02)||$7.07 million||View||N/A|
Dynatronics (NASDAQ:DYNT) Earnings Estimates
Current Year EPS Consensus Estimate: $-0.45 EPS
Next Year EPS Consensus Estimate: $-0.09 EPS
Dividend History for Dynatronics (NASDAQ:DYNT)
No dividend announcements for this company have been tracked by MarketBeat.com
Dynatronics (NASDAQ DYNT) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 51.80%
Institutional Ownership Percentage: 27.10%
Dynatronics (NASDAQ DYNT) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|1/3/2018||Brian Larkin||Director||Buy||1,366||$2.77||$3,783.82||81,642|| |
|1/3/2018||David Alma Wirthlin||CFO||Buy||81||$2.77||$224.37||257|| |
|1/3/2018||Stuart Essig||Major Shareholder||Buy||27,455||$2.77||$76,050.35||856,169|| |
|1/3/2018||Thomas J Gephart||VP||Buy||113||$2.77||$313.01||5,319|| |
|11/30/2017||Brian Larkin||Director||Buy||40,000||$2.50||$100,000.00||80,276|| |
|11/30/2017||Ventures 1 Lp Provco||Major Shareholder||Buy||300,000||$2.50||$750,000.00||586,944|| |
Dynatronics (NASDAQ DYNT) News Headlines
Dynatronics (NASDAQ:DYNT) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Dynatronics (NASDAQ:DYNT) Income Statement, Balance Sheet and Cash Flow Statement
Dynatronics (NASDAQ DYNT) Stock Chart for Saturday, March, 24, 2018